SCHEMBL6776203

SCHEMBL6776203

Cc1ccc(S(=O)(=O)Nc2ccc(C3=NCCc4ccc(Oc5ccccc5)cc43)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.60
PGR P06401 7/20 0.49
GFER P55789 1/20 0.48
CYP2C9 P11712 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
FFAR4 Q5NUL3 1/20 0.47
AR P10275 1/20 0.45
CACNA1B Q00975 1/20 0.45
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724676 0.89 PGR (0.62) FFAR1PGRFFAR4
SCHEMBL6718287 0.88 FFAR1 (0.47) FFAR1PGRFFAR4AR
SCHEMBL6718280 0.83 PGR (0.66) PGRARLMNA
SCHEMBL6716436 0.82 ALDH1A1 (0.48) GFERSMN1; SMN2KDM4ELMNAALDH1A1
SCHEMBL6715044 0.81 PGR (0.42) FFAR1PGRFFAR4ARCA1
SCHEMBL7160300 0.81 ALDH1A1 (0.39) FFAR1HTTSMN1; SMN2CA1CA2
SCHEMBL6715048 0.81 PGR (0.41) FFAR1PGRAR
SCHEMBL8752475 0.78 FFAR1 (1.00) FFAR1PGRGFERCYP2C9CYP1A2
SCHEMBL6720396 0.76 KMT2A (0.51) PGRCYP2C9LMNAALDH1A1MEN1
SCHEMBL6718222 0.76 CA1 (0.47) SMN1; SMN2CA1CA2CA9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818651-B2 ANTIINFLAMMATORY, ANTIASTHMATIC, SKIN, AND AUTOIMMUNE DISORDERS; CROHN*S DISEASE, ULCERATIVE COLITIS, CONJUCTIVITIS, MULTIPLE SCLEROSIS, AND RHEUMATOID ARTHRITIS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ALTANA PHARMA AG (DE) 2004-11-16 US disclosed
EP-1337515-A1 (DIHYDRO)ISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2003-08-27 EP disclosed
WO-2002040450-A1 (DIHYDRO)ISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS ALTANA PHARMA AG (DE) 2002-05-23 WO disclosed